Showing 16,741 - 16,760 results of 103,027 for search '(( a step decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.62s Refine Results
  1. 16741
  2. 16742

    TMD-5 intrinsic Trp fluorescence assay. by Xiaohui Wang (19899)

    Published 2012
    “…(b), Pentamidine decreases Trp emission fluorescence intensity of TMD-5 in 150 µM C14 betaine and 50 mM HEPES (pH = 7.4) buffer in a dose-dependent manner. …”
  3. 16743

    Inhibition correlates with cellular PmV levels. by Luca Gambini (826027)

    Published 2015
    “…DC6 clone expresses PmV-GFP chimera under regulation of the native promoter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]; G6 clone, the PmV-GFP-DD chimera under regulation of the native promoter (this paper) and #3 clone (episomally expressing PmV-GFP chimera under <i>Hsp86-5'</i>, a strong and constitutive promoter) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]. …”
  4. 16744

    MCPyV circALTO can be translated. by Rong Yang (107028)

    Published 2021
    “…<p>(A) CircALTOs do not inhibit MCPyV miRNA function in vitro. 293 cells were transfected with <i>Renilla</i> luciferase reporter with a 300 nucleotide region complementary to the MCPyV miRNA and the indicated plasmids including a MCPyV-miRNA-M1 expression plasmid (derived from isolate MCV350), pCDNA3.1 control vector, pCDNA circALTO1 (pcircALTO1) or pCDNA circALTO2 (pcircALTO2) expression plasmid. …”
  5. 16745

    V2G controls parameters [36]. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  6. 16746
  7. 16747

    Dynacortin facilitates polarization of chemotaxing cells-5 by Cathryn Kabacoff (40205)

    Published 2011
    “…A total of 2.5 M actin was present in each sample. …”
  8. 16748

    Plants components in five-flower remedy [24]. by Walaiporn Plirat (17775628)

    Published 2025
    “…This study aimed to explore the potential antimalarial and neuroprotective properties of the five-flower remedy (FFR), a traditional herbal formulation, in experimental cerebral malaria (ECM). …”
  9. 16749

    Five multi-target tracking evaluation indexes. by Wenshun Sheng (21485393)

    Published 2025
    “…<div><p>A real-time stable multi-target tracking method based on the enhanced You Only Look Once-v8 (YOLOv8) and the optimized Simple Online and Realtime Tracking with a Deep association metric (DeepSORT) for real-time stable multi-target tracking (S-YOFEO) is proposed to address the issue of target ID transformation and loss caused by the increase of practical background complexity. …”
  10. 16750

    BAG5 inhibited PINK1 degradation. by Xuejing Wang (514409)

    Published 2014
    “…<p><b>A:</b> HEK-293 cells were transfected with EGFP-N3, EGFP-BAG5, negative control siRNA (NC) or BAG5 siRNA for 24 h or 48 h. …”
  11. 16751
  12. 16752

    Ctcf and Smarca5 interact in AML cells. by Martina Dluhosova (519144)

    Published 2014
    “…D Smarca5 at ICR upon Ctcf knockdown. Occupancy of Smarca5 (lysates from 1A) by ChIP. …”
  13. 16753

    The Synergistic Roles of Cholecystokinin B and Dopamine D<sub>5</sub> Receptors on the Regulation of Renal Sodium Excretion by Xiaoliang Jiang (845022)

    Published 2016
    “…The natriuresis in salt-loaded BALB/c mice was decreased by YF476, a CCK<sub>B</sub>R antagonist and Sch23390, a D<sub>1</sub>R/D<sub>5</sub>R antagonist. …”
  14. 16754

    Five onset times and results for musculoskeletal simulation. by Jiyoun Kim (3364571)

    Published 2022
    “…<p>(A) The five different onset times were at 12%, 18%, 24%, 30%, and 36% of the gait cycle. …”
  15. 16755

    Patients’ responses to EQ5-D items. by Walid Al-Qerem (3760027)

    Published 2024
    “…</p><p>Result</p><p>This study included 68.8% females, with a median age of 58 (50–64) years. The median EQ5-D index score was 0.66 (0.41–0.78). …”
  16. 16756

    Evaluation of PNA effect on CD5 expression. by Elena Cesaro (11424301)

    Published 2022
    “…Cells transfected with <b>PNA</b> showed a decreased CD5 mRNA expression, differently from cells transfected with <b>scrambled PNA</b> used as negative control. …”
  17. 16757

    Image_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.JPEG by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
  18. 16758

    Table_5_Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.DOCX by Jingxuan Shan (4711089)

    Published 2019
    “…We found a highly significant association between the CCND1 rs614367-TT genotype (OR = 5.14; P = 0.004) and TNBC risk, and identified a significant association between the rs614367-T allele and decreased PFS in TNBC. …”
  19. 16759

    Supporting data for Figs 3, 4 and 5. by Oliver Eales (11495186)

    Published 2023
    “…During periods of vaccination rollout, and the emergence of the Omicron variant, the IFR and IHR decreased. During 2020, we estimated a time-lag of 19 days between hospitalisation and swab positivity, and 26 days between deaths and swab positivity. …”
  20. 16760